No photo of David S Rubenstein
Contact Expert

View Scopus Profile

David S Rubenstein

    • 1790 Citations
    • 24 h-Index
    1988 …2021
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 8 Similar Profiles
    Pemphigus Medicine & Life Sciences
    Acantholysis Medicine & Life Sciences
    Keratinocytes Medicine & Life Sciences
    Autoantibodies Medicine & Life Sciences
    Bullous Pemphigoid Medicine & Life Sciences
    Immunoglobulin G Medicine & Life Sciences
    alpha-Macroglobulins Medicine & Life Sciences
    Autoimmune Diseases Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 1988 2021

    C0168Z03 A Multicenter, Open Registry of Patients with Psoriasis Who Are Cand

    Rubenstein, D. S. & Lugo-Somolinos, A.

    Industry Sponsor

    12/1/08 → 6/30/21

    Project: Research project

    Psoriasis
    Registries
    Biological Therapy
    Comorbidity
    Quality of Life

    A3921079 A Phase 3, multi-site, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of 2 oral doses of CP-690,550 in subjects with moderate to severe chronic plaque psoriasis

    Rubenstein, D. S. & Lugo-Somolinos, A.

    Industry Sponsor

    4/1/11 → 3/31/14

    Project: Research project

    Psoriasis
    Placebos
    Safety
    Janus Kinases
    Phosphotransferases

    P10-023 A 10-Year, Post-Marketing, Observational Registry of HUMIRA (Adalimu

    Rubenstein, D. S. & Lugo-Somolinos, A.

    Industry Sponsor

    6/23/09 → 6/22/17

    Project: Research project

    antineoplaston A10
    Marketing
    Registries
    Psoriasis
    Safety

    COV-BAP01346 Efficacy and Safety of Alitretinoin in the Treatment of Severe C

    Morrell, D. S., Rubenstein, D. S. & Lugo-Somolinos, A.

    Industry Sponsor

    3/14/09 → 3/13/12

    Project: Research project

    Safety
    Eczema
    Placebos
    Hand
    Therapeutics

    DPSI-IDP107-PS-01 A Phase 2B, Multi-Center, Double-Blind, Randomized, Dose-Ra

    Rubenstein, D. S. & Lugo-Somolinos, A.

    Industry Sponsor

    7/30/08 → 7/29/11

    Project: Research project

    Inosine Diphosphate
    Acne Vulgaris
    Placebos
    Tablets
    Safety

    Research Output 1991 2015

    Apoptosis and Signaling in Bullous Diseases: Pemphigus

    Rubenstein, D. S. & Pincelli, C., Jan 1 2015, Blistering Diseases: Clinical Features, Pathogenesis, Treatment. Springer Berlin Heidelberg, p. 141-152 12 p.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

    Pemphigus
    Apoptosis
    Bullous Pemphigoid
    Pemphigoid Gestationis
    Epidermolysis Bullosa Acquisita
    38 Citations

    Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts

    Murrell, D. F. , Marinovic, B. , Caux, F. , Prost, C. , Ahmed, R. , Wozniak, K. , Amagai, M. , Bauer, J. , Beissert, S. , Borradori, L. , Culton, D. , Fairley, J. A. , Fivenson, D. , Jonkman, M. F. , Marinkovich, M. P. , Woodley, D. , Zone, J. , Aoki, V. , Bernard, P. , Bruckner-Tuderman, L. & 24 others Cianchini, G., Venning, V., Diaz, L., Eming, R., Grando, S. A., Hall, R. P., Hashimoto, T., Herrero-González, J. E., Hertl, M., Joly, P., Karpati, S., Kim, J., Chan Kim, S., Korman, N. J., Kowalewski, C., Lee, S. E., Rubenstein, D. R., Sprecher, E., Yancey, K., Zambruno, G., Zillikens, D., Doan, S., Daniel, B. S. & Werth, V. P., Jan 1 2015, In : Journal of the American Academy of Dermatology. 72, 1, p. 168-174 7 p.

    Research output: Contribution to journal › Review article

    Bullous Pemphigoid
    Mucous Membrane
    Outcome Assessment (Health Care)
    Autoimmune Diseases
    Blister
    2 Citations

    IL2 inducible T-cell kinase, a novel therapeutic target in Melanoma

    Carson, C. C. , Moschos, S. J. , Edmiston, S. N. , Darr, D. B. , Nikolaishvili-Feinberg, N. , Groben, P. A. , Zhou, X. , Kuan, P. F. , Pandey, S. , Chan, K. T. , Jordan, J. L. , Hao, H. , Frank, J. S. , Hopkinson, D. A. , Gibbs, D. C. , Alldredge, V. D. , Parrish, E. , Hanna, S. C. , Berkowitz, P. , Rubenstein, D. S. & 6 others Miller, C. R., Bear, J. E., Ollila, D. W., Sharpless, N. E., Conway, K. & Thomas, N. E., May 1 2015, In : Clinical Cancer Research. 21, 9, p. 2167-2176 10 p.

    Research output: Contribution to journal › Article

    Melanoma
    Therapeutics
    Cell Line
    Nevus
    emt protein-tyrosine kinase
    4 Citations

    Targeting O-Glycosyltransferase (OGT) to promote healing of diabetic skin wounds

    Runage, K., Bektas, M., Berkowitz, P. & Rubenstein, D. S., Feb 28 2014, In : Journal of Biological Chemistry. 289, 9, p. 5462-5466 5 p.

    Research output: Contribution to journal › Article

    Glycosyltransferases
    Skin
    Wounds and Injuries
    Proteins
    Wound Healing
    31 Citations

    A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis

    Bektas, M., Jolly, P. S., Berkowitz, P., Amagai, M. & Rubenstein, D. S., Mar 29 2013, In : Journal of Biological Chemistry. 288, 13, p. 9447-9456 10 p.

    Research output: Contribution to journal › Article

    Acantholysis
    Pemphigus
    Epidermal Growth Factor Receptor
    Immunoglobulin G
    p38 Mitogen-Activated Protein Kinases